Both in Pharmaceuticals
Alumis vs Latigo Biotherapeutics
Over the past year ALMS returned −28.6% and LTGO returned −36.6%; their daily moves had a correlation of 0.41.
ALMS −28.6% LTGO −36.6%Growth of $1, one year, split-adjusted
| Metric | ALMS | LTGO |
|---|---|---|
| Price | $6.55 | $14.04 |
| Market cap | $847.8M | $930.8M |
| Today | +0.77% | −3.64% |
| 1 month | −5.5% | −13.7% |
| 6 months | −74.3% | — |
| Year to date | −32.9% | — |
| 1 year | +43.6% | — |
| Revenue growth (YoY) | −37.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −8557.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 114.6× | — |
| Net cash | $502.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 180.1% | — |
| Short % of float | 11.3% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).